Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Nov-23 7:29 PM View:  | Goldman Sachs Group Inc/ 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 08-Nov-23 | Sale | 72,874 | $0.71 | $51,740.50 | (15%) 470.83K to 397.95K | |
| 14-Sep-23 4:06 PM View: | Jacob Jeffrey E. Director | Panbela Therapeutics, Inc. (PBLA) | 12-Sep-23 | Gift | 275 | -- | -- | (91%) 0.3K to 27 | |
| 01-Feb-23 4:37 PM View: | Simpson Jennifer K. President and CEO Director | Panbela Therapeutics, Inc. (PBLA) | 30-Jan-23 | Purchase | 4,444 | -- | -- | 130% 3.42K to 7.87K | |
| 01-Feb-23 4:36 PM View: | Horvath Susan V.P. of Finance & CFO | Panbela Therapeutics, Inc. (PBLA) | 30-Jan-23 | Purchase | 4,444 | -- | -- | 33% 13.44K to 17.88K | |
| 06-Oct-22 6:14 PM View: | Cullen Michael T. Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 04-Oct-22 | Purchase | 165,000 | -- | -- | 39% 421.39K to 586.39K | |
| 06-Oct-22 5:26 PM View: | Schemel Donald Robert Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 04-Oct-22 | Purchase | 200,000 | -- | -- | 53% 379.27K to 579.27K | |
| 06-Oct-22 5:24 PM View: | Jacob Jeffrey E. Director | Panbela Therapeutics, Inc. (PBLA) | 04-Oct-22 | Purchase | 33,000 | -- | -- | 10% 334.08K to 367.08K | |
| 27-May-21 8:54 PM View: | Fratamico Arthur Director | Panbela Therapeutics, Inc. (PBLA) | 25-May-21 | Grant | 4,316 | -- | -- | 81% 5.3K to 9.62K | |
| 27-May-21 8:49 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 25-May-21 | Grant | 4,316 | -- | -- | 2% 193.02K to 197.34K | |
| 27-May-21 8:51 PM View: | Mathiesen Jeffrey S Director | Panbela Therapeutics, Inc. (PBLA) | 25-May-21 | Grant | 4,316 | -- | -- | 73% 5.88K to 10.19K | |
| 27-May-21 8:48 PM View: | Cullen Michael T. Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 25-May-21 | Grant | 4,316 | -- | -- | 1% 417.07K to 421.39K | |
| 27-May-21 8:52 PM View: | Schemel Donald Robert Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 25-May-21 | Grant | 4,316 | -- | -- | 1% 374.96K to 379.27K | |
| 11-Jun-21 10:34 AM View: | Gagnon Suzanne Director | Panbela Therapeutics, Inc. (PBLA) | 29-Apr-21 | Gift | 1,000 | -- | -- | (2%) 47.28K to 46.28K | |
| 11-Jun-21 10:34 AM View: | Gagnon Suzanne Director | Panbela Therapeutics, Inc. (PBLA) | 06-Jan-21 | Gift | 7,142 | -- | -- | (13%) 54.43K to 47.28K | |
| 11-Jun-21 10:34 AM View: | Gagnon Suzanne Director | Panbela Therapeutics, Inc. (PBLA) | 06-Jan-21 | Gift | 3,284 | -- | -- | 6% 51.14K to 54.43K | |
| 03-Dec-20 4:13 PM View: | Mathiesen Jeffrey S Director | Panbela Therapeutics, Inc. (PBLA) | 01-Dec-20 | Grant | 2,875 | -- | -- | 96% 3.0K to 5.88K | |
| 03-Dec-20 4:12 PM View: | Schemel Donald Robert Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 01-Dec-20 | Grant | 2,875 | -- | -- | < 1% 372.08K to 374.96K | |
| 03-Dec-20 4:11 PM View: | Fratamico Arthur Director | Panbela Therapeutics, Inc. (PBLA) | 01-Dec-20 | Grant | 2,875 | -- | -- | 119% 2.42K to 5.3K | |
| 03-Dec-20 4:15 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 01-Dec-20 | Grant | 2,875 | -- | -- | 2% 190.09K to 192.96K | |
| 14-Sep-20 5:52 PM View: | Simpson Jennifer K. President and CEO Director | Panbela Therapeutics, Inc. (PBLA) | 10-Sep-20 | Market Purchase | 1,000 | $2.74 | $2,737.10 | 41% 2.42K to 3.42K | 31% |
| 09-Sep-20 9:28 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 08-Sep-20 | Market Purchase | 225 | $2.55 | $573.75 | < 1% 189.86K to 190.09K | |
| 09-Sep-20 9:28 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 04-Sep-20 | Market Purchase | 24,775 | $2.51 | $62,158.00 | 15% 165.09K to 189.86K | |
| 01-Sep-20 5:45 PM View: | Cullen Michael T. Exec. Chairman, Pres. & CEO Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 01-Sep-20 | Purchase | 10,000 | -- | -- | 2% 402.57K to 412.57K | |
| 01-Sep-20 5:48 PM View: | Fratamico Arthur Director | Panbela Therapeutics, Inc. (PBLA) | 01-Sep-20 | Purchase | 2,424 | -- | -- | 100% 0 to 2.42K | |
| 01-Sep-20 5:48 PM View: | Horvath Susan V.P. of Finance & CFO | Panbela Therapeutics, Inc. (PBLA) | 01-Sep-20 | Purchase | 2,424 | -- | -- | 22% 11.01K to 13.44K | |
| 01-Sep-20 5:47 PM View: | Simpson Jennifer K. President and CEO Director | Panbela Therapeutics, Inc. (PBLA) | 01-Sep-20 | Purchase | 2,424 | -- | -- | 100% 0 to 2.42K | |
| 09-Jun-20 6:19 PM View: | Horvath Susan V.P. of Finance & CFO | Panbela Therapeutics, Inc. (PBLA) | 05-Jun-20 | Purchase | 2,500 | -- | -- | 29% 8.51K to 11.01K | |
| 09-Jun-20 6:20 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 05-Jun-20 | Purchase | 10,000 | -- | -- | 6% 155.09K to 165.09K | |
| 27-May-20 3:22 PM View: | Cullen Michael T. Exec. Chairman, Pres. & CEO Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 22-May-20 | Purchase | 10,000 | -- | -- | 3% 392.57K to 402.57K | |
| 24-Sep-19 5:35 PM View: | Gagnon Suzanne Director | Panbela Therapeutics, Inc. (PBLA) | 20-Sep-19 | Purchase | 7,142 | -- | -- | 16% 44.0K to 51.14K | |
| 24-Sep-19 5:35 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 20-Sep-19 | Purchase | 30,000 | -- | -- | 24% 125.08K to 155.09K | |
| 04-Sep-19 5:44 PM View: | Cullen Michael T. Exec. Chairman, Pres. & CEO Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 30-Aug-19 | Purchase | 30,000 | -- | -- | 8% 362.57K to 392.57K | |
| 04-Sep-19 5:45 PM View: | Horvath Susan V.P. of Finance & CFO | Panbela Therapeutics, Inc. (PBLA) | 30-Aug-19 | Purchase | 1,428 | -- | -- | 20% 7.08K to 8.51K | |
| 26-Aug-19 9:17 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 16-Aug-19 | Sale | 343,411 | $3.00 | $1,030,230.00 | (62%) 555.54K to 212.13K | |
| 02-Jul-19 4:53 PM View: | Cullen Michael T. Exec. Chairman, Pres. & CEO Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 30-Jun-19 | Conversion | 10,495 | -- | -- | 3% 352.08K to 362.57K | |
| 02-Jul-19 4:54 PM View: | Horvath Susan V.P. of Finance & CFO | Panbela Therapeutics, Inc. (PBLA) | 30-Jun-19 | Conversion | 7,084 | -- | -- | 100% 0 to 7.08K | |
| 24-Jan-19 11:59 AM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 15-Aug-18 | Sale | 47,025 | -- | -- | (8%) 602.56K to 555.54K | |
| 14-Jun-18 5:06 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 16-May-18 | Purchase | 5,000 | -- | -- | < 1% 1.1M to 1.1M | |
| 14-Jun-18 5:20 PM View: | Kaysen David B President and CEO Director | Panbela Therapeutics, Inc. (PBLA) | 16-May-18 | Purchase | 1,000 | -- | -- | 2% 50.0K to 51.0K | |
| 14-Jun-18 5:06 PM View: | Schaffer Paul W. Director | Panbela Therapeutics, Inc. (PBLA) | 16-May-18 | Conversion | 11,756 | -- | -- | 1% 1.08M to 1.1M | |
| 29-May-18 6:31 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 16-May-18 | Conversion | 47,025 | -- | -- | 8% 583.54K to 630.56K | |
| 22-Feb-18 5:37 PM View: | Cullen Michael T. Executive Chairman Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 20-Feb-18 | Purchase | 5,000 | -- | -- | 1% 347.08K to 352.08K | |
| 22-Feb-18 5:28 PM View: | Kellen Scott Chief Financial Officer | Panbela Therapeutics, Inc. (PBLA) | 20-Feb-18 | Purchase | 1,000 | -- | -- | 29% 3.5K to 4.5K | |
| 22-Feb-18 5:30 PM View: | Mathiesen Jeffrey S Director | Panbela Therapeutics, Inc. (PBLA) | 20-Feb-18 | Purchase | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 15-Dec-17 9:49 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 13-Dec-17 | Payment of Exercise | 11,512 | $13.03 | $150,001.00 | (2%) 595.05K to 583.54K | |
| 15-Dec-17 9:49 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 13-Dec-17 | Option Exercise | 80,000 | $1.88 | $150,000.00 | 16% 515.05K to 595.05K | |
| 29-Mar-17 5:05 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 27-Mar-17 | Grant | 280,000 | $0.75 | $210,000.00 | 6% 4.87M to 5.15M | |
| 29-Mar-17 5:05 PM View: | Gilbertson Ryan Randall 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 27-Mar-17 | Grant | 700,000 | $0.75 | $525,000.00 | 17% 4.17M to 4.87M | |
| 14-Feb-17 10:00 PM View: | Cullen Michael T. Executive Chairman Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 21-Dec-16 | Gift | 45,000 | -- | -- | (1%) 3.52M to 3.47M | |
| 01-Dec-16 5:07 PM View: | Schemel Donald Robert Director 10% Owner | Panbela Therapeutics, Inc. (PBLA) | 14-Nov-16 | Sale | 7,000 | $1.43 | $10,010.00 | (< 1%) 3.73M to 3.72M |
